I Turesson

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

J. Shah, U. Mellqvist, M. Dimopoulos, 2014, Leukemia.

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

M Boccadoro, B. Barlogie, G. Morgan, 2009, Leukemia.

Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

A. Waage, A. Sundan, N. Abildgaard, 2000, Blood.

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.

Mike Clarke, K Wheatley, A Riccardi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International uniform response criteria for multiple myeloma

M. Beksac, B. Barlogie, K. Anderson, 2006, Leukemia.